CN102608325A - 脂肪酸结合蛋白(fatty acid-binding proteins,H-FABP)测定试剂盒(胶乳增强免疫比浊法) - Google Patents
脂肪酸结合蛋白(fatty acid-binding proteins,H-FABP)测定试剂盒(胶乳增强免疫比浊法) Download PDFInfo
- Publication number
- CN102608325A CN102608325A CN2011102152927A CN201110215292A CN102608325A CN 102608325 A CN102608325 A CN 102608325A CN 2011102152927 A CN2011102152927 A CN 2011102152927A CN 201110215292 A CN201110215292 A CN 201110215292A CN 102608325 A CN102608325 A CN 102608325A
- Authority
- CN
- China
- Prior art keywords
- fabp
- reagent
- solution
- kit
- latex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000011026 Fatty Acid Binding Protein 3 Human genes 0.000 title claims abstract description 64
- 108010062715 Fatty Acid Binding Protein 3 Proteins 0.000 title claims abstract description 64
- 239000004816 latex Substances 0.000 title claims abstract description 28
- 229920000126 latex Polymers 0.000 title claims abstract description 28
- 238000003556 assay Methods 0.000 title abstract description 6
- 102000030914 Fatty Acid-Binding Human genes 0.000 title description 4
- 108091022862 fatty acid binding Proteins 0.000 title description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 35
- 210000002966 serum Anatomy 0.000 claims abstract description 15
- 239000003381 stabilizer Substances 0.000 claims abstract description 9
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 8
- 239000004094 surface-active agent Substances 0.000 claims abstract 2
- 238000013016 damping Methods 0.000 claims description 18
- 239000012530 fluid Substances 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 11
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 5
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims description 5
- 238000004879 turbidimetry Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 4
- 244000309466 calf Species 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- CCMKPCBRNXKTKV-UHFFFAOYSA-N 1-hydroxy-5-sulfanylidenepyrrolidin-2-one Chemical compound ON1C(=O)CCC1=S CCMKPCBRNXKTKV-UHFFFAOYSA-N 0.000 claims description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 150000001718 carbodiimides Chemical class 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 2
- 239000012482 calibration solution Substances 0.000 claims 1
- 230000021523 carboxylation Effects 0.000 claims 1
- 238000006473 carboxylation reaction Methods 0.000 claims 1
- 238000000247 postprecipitation Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 16
- 239000007853 buffer solution Substances 0.000 abstract description 6
- 238000002965 ELISA Methods 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 238000011088 calibration curve Methods 0.000 abstract description 3
- 238000010790 dilution Methods 0.000 abstract description 3
- 239000012895 dilution Substances 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 229910017053 inorganic salt Inorganic materials 0.000 abstract 1
- 239000004005 microsphere Substances 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 description 9
- 239000002245 particle Substances 0.000 description 8
- 210000002381 plasma Anatomy 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000004413 cardiac myocyte Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000003680 myocardial damage Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000003118 sandwich ELISA Methods 0.000 description 2
- 101800000263 Acidic protein Proteins 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 101100226596 Gallus gallus FABP gene Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000003150 biochemical marker Substances 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical group [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000005059 placental tissue Anatomy 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Substances [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110215292.7A CN102608325B (zh) | 2012-02-24 | 2012-02-24 | 心型脂肪酸结合蛋白(h-fabp)测定试剂盒(胶乳增强免疫比浊法) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110215292.7A CN102608325B (zh) | 2012-02-24 | 2012-02-24 | 心型脂肪酸结合蛋白(h-fabp)测定试剂盒(胶乳增强免疫比浊法) |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102608325A true CN102608325A (zh) | 2012-07-25 |
CN102608325B CN102608325B (zh) | 2016-08-24 |
Family
ID=46525864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110215292.7A Active CN102608325B (zh) | 2012-02-24 | 2012-02-24 | 心型脂肪酸结合蛋白(h-fabp)测定试剂盒(胶乳增强免疫比浊法) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102608325B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102788880A (zh) * | 2012-08-16 | 2012-11-21 | 北京恩济和生物科技有限公司 | 一种心型脂肪酸结合蛋白检测试剂盒及其制备方法 |
CN103063830A (zh) * | 2012-12-21 | 2013-04-24 | 杭州茂天赛科技有限公司 | 一种elisa预包被酶标板的制备方法 |
CN103123319A (zh) * | 2012-12-20 | 2013-05-29 | 武汉生之源生物科技有限公司 | 心型脂肪酸结合蛋白含量检测试剂盒及其制备方法 |
CN103760358A (zh) * | 2013-11-12 | 2014-04-30 | 赵铁铭 | 一种用于检测冯维勒布兰德因子的试剂及其制备方法和应用 |
WO2014121715A1 (zh) * | 2013-02-05 | 2014-08-14 | 北京九强生物技术股份有限公司 | 25羟维生素d检测试剂盒及其制备方法 |
CN105911297A (zh) * | 2016-07-07 | 2016-08-31 | 宏葵生物(中国)有限公司 | 胶乳增强免疫比浊法检测心型脂肪酸结合蛋白的试剂盒 |
CN105954523A (zh) * | 2016-07-14 | 2016-09-21 | 宏葵生物(中国)有限公司 | 一种心肌肌钙蛋白i检测试剂盒 |
CN106442355A (zh) * | 2016-09-29 | 2017-02-22 | 浙江达美生物技术有限公司 | 心型脂肪酸结合蛋白的测定试剂及其制备方法 |
CN107860930A (zh) * | 2017-11-10 | 2018-03-30 | 苏州康和顺医疗技术有限公司 | 一种心型脂肪酸结合蛋白的免疫比浊检测试剂和方法 |
CN117491646A (zh) * | 2023-11-13 | 2024-02-02 | 深圳上泰生物工程有限公司 | 一种心型脂肪酸结合蛋白的检测试剂盒及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0431762A (ja) * | 1990-05-28 | 1992-02-03 | Dainippon Pharmaceut Co Ltd | 心筋梗塞の判定方法 |
US6248597B1 (en) * | 1997-08-11 | 2001-06-19 | Roche Diagnostics Corporation | Microparticle enhanced light scattering agglutination assay |
CN1790022A (zh) * | 2005-12-19 | 2006-06-21 | 孟衍建 | 精子结合抗体检测试剂及其制备方法 |
US20080183062A1 (en) * | 2004-02-23 | 2008-07-31 | Hiroshi Hazui | Method of Distinguishing Among Type a and Type B Acute Aortic Dissection and Acute Myocardial Infraction and Kit For Distinguishment |
-
2012
- 2012-02-24 CN CN201110215292.7A patent/CN102608325B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0431762A (ja) * | 1990-05-28 | 1992-02-03 | Dainippon Pharmaceut Co Ltd | 心筋梗塞の判定方法 |
US6248597B1 (en) * | 1997-08-11 | 2001-06-19 | Roche Diagnostics Corporation | Microparticle enhanced light scattering agglutination assay |
US20080183062A1 (en) * | 2004-02-23 | 2008-07-31 | Hiroshi Hazui | Method of Distinguishing Among Type a and Type B Acute Aortic Dissection and Acute Myocardial Infraction and Kit For Distinguishment |
CN1790022A (zh) * | 2005-12-19 | 2006-06-21 | 孟衍建 | 精子结合抗体检测试剂及其制备方法 |
Non-Patent Citations (4)
Title |
---|
MARKUS ROBERS, ET AL: "Development of a Rapid Microparticle-enhanced Turbidimetric Immunoassay for Plasma Fatty Acid-binding Protein, an Early Marker of Acute Myocardial Infarction", 《CLINICAL CHEMISTRY》 * |
MARKUS ROBERS, ET AL: "Development of a Rapid Microparticle-enhanced Turbidimetric Immunoassay for Plasma Fatty Acid-binding Protein, an Early Marker of Acute Myocardial Infarction", 《CLINICAL CHEMISTRY》, vol. 44, no. 7, 31 December 1998 (1998-12-31) * |
YEONGSIC KIM,ET AL: "Automated Heart-Type Fatty Acid–Binding Protein Assay for the Early Diagnosis of Acute Myocardial Infarction", 《AM J CLIN PATHOL》 * |
冯建忠 李铁军: "心型脂肪酸结合蛋白的临床应用及测定方法研究进展", 《临床和实验医学杂志》 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102788880A (zh) * | 2012-08-16 | 2012-11-21 | 北京恩济和生物科技有限公司 | 一种心型脂肪酸结合蛋白检测试剂盒及其制备方法 |
CN103123319A (zh) * | 2012-12-20 | 2013-05-29 | 武汉生之源生物科技有限公司 | 心型脂肪酸结合蛋白含量检测试剂盒及其制备方法 |
CN103123319B (zh) * | 2012-12-20 | 2015-04-15 | 武汉生之源生物科技有限公司 | 心型脂肪酸结合蛋白含量检测试剂盒及其制备方法 |
CN103063830B (zh) * | 2012-12-21 | 2016-04-13 | 杭州茂天赛科技有限公司 | 一种elisa预包被酶标板的制备方法 |
CN103063830A (zh) * | 2012-12-21 | 2013-04-24 | 杭州茂天赛科技有限公司 | 一种elisa预包被酶标板的制备方法 |
WO2014121715A1 (zh) * | 2013-02-05 | 2014-08-14 | 北京九强生物技术股份有限公司 | 25羟维生素d检测试剂盒及其制备方法 |
CN103760358A (zh) * | 2013-11-12 | 2014-04-30 | 赵铁铭 | 一种用于检测冯维勒布兰德因子的试剂及其制备方法和应用 |
CN105911297A (zh) * | 2016-07-07 | 2016-08-31 | 宏葵生物(中国)有限公司 | 胶乳增强免疫比浊法检测心型脂肪酸结合蛋白的试剂盒 |
CN105911297B (zh) * | 2016-07-07 | 2018-03-16 | 宏葵生物(中国)有限公司 | 胶乳增强免疫比浊法检测心型脂肪酸结合蛋白的试剂盒 |
CN105954523A (zh) * | 2016-07-14 | 2016-09-21 | 宏葵生物(中国)有限公司 | 一种心肌肌钙蛋白i检测试剂盒 |
CN106442355A (zh) * | 2016-09-29 | 2017-02-22 | 浙江达美生物技术有限公司 | 心型脂肪酸结合蛋白的测定试剂及其制备方法 |
CN107860930A (zh) * | 2017-11-10 | 2018-03-30 | 苏州康和顺医疗技术有限公司 | 一种心型脂肪酸结合蛋白的免疫比浊检测试剂和方法 |
CN117491646A (zh) * | 2023-11-13 | 2024-02-02 | 深圳上泰生物工程有限公司 | 一种心型脂肪酸结合蛋白的检测试剂盒及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102608325B (zh) | 2016-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102608325A (zh) | 脂肪酸结合蛋白(fatty acid-binding proteins,H-FABP)测定试剂盒(胶乳增强免疫比浊法) | |
CN102680698B (zh) | 中性粒细胞明胶酶相关脂质运载蛋白(ngal)测定试剂盒(胶乳增强免疫比浊法) | |
AU680270B2 (en) | Method for non-competitive binding assays | |
CN102692507A (zh) | 脂蛋白相关磷脂酶a2(lppla2)测定试剂盒(胶乳增强免疫比浊法) | |
CN102841206B (zh) | 肌钙蛋白T(Troponin-T,TNT)测定试剂盒 | |
CN108152512A (zh) | 肝素结合蛋白检测试剂盒及其制备方法 | |
CN101526520B (zh) | 一种生物样品的检测方法及装置 | |
CN108414766A (zh) | 用于定量检测糖尿病自身抗体的试剂盒及其应用 | |
US20220113322A1 (en) | Rapid measurement of total vitamin d in blood | |
CN103149370A (zh) | 脂蛋白(a)检测试剂盒 | |
CN104034892A (zh) | 一种肿瘤标志物afp磁微粒化学发光免疫分析试剂盒及其检测方法 | |
KR0126236B1 (ko) | 완전 세포에 적용할 수 있는 면역측정분석 키트 및 방법 | |
CN108051439A (zh) | 一种单试剂肝素结合蛋白检测试剂盒及其制备方法 | |
CN104237513A (zh) | 一种甲状腺过氧化物酶抗体磁微粒化学发光免疫定量检测试剂盒 | |
Yamamoto et al. | Automated homogeneous liposome-based assay system for total complement activity | |
CN108459162A (zh) | 检测多种炎症生物标志物的方法及其试剂盒 | |
CN108603880A (zh) | 受试物质的检测方法及受试物质的检测用试剂盒 | |
CA2286414A1 (en) | Non-separation heterogenous assay for biological substance | |
JPH01248061A (ja) | 試験キットおよび免疫リガンドの測定方法 | |
JP4197393B2 (ja) | IgA腎症の検査法 | |
JPWO1999050663A6 (ja) | IgA腎症の検査法 | |
CN101315379A (zh) | 一种用于检测莱克多巴胺的试剂盒及其应用 | |
JP2005506515A (ja) | 多種検定用の標準希釈液 | |
EP0106615B1 (en) | Assay for the free portion of substances in biological fluids | |
US20140011190A1 (en) | Method for performing a rapid test |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 210031 building E, building 10, Spark Road, No. four, Spark Road, Nanjing hi tech Development Zone, Jiangsu, China Applicant after: NANJING NORMAN BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 5, 210029 building, 66-1 software building, Majiagou industrial district, Nanjing District, Yuhuatai, Jiangsu Applicant before: NANJING NORMAN BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: He Shibiao Document name: Notification of Passing Examination on Formalities |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 197 Yaogu Avenue, Jiangbei New District, Nanjing City, Jiangsu Province, 211899 Patentee after: Nanjing Norman Biotechnology Co.,Ltd. Country or region after: China Address before: 210031 4th floor, e building, talent building, No.10 Xinghuo Road, high tech Development Zone, Nanjing City, Jiangsu Province Patentee before: NANJING NORMAN BIOLOGICAL TECHNOLOGY Co.,Ltd. Country or region before: China |